Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, Hong Kong.
Hong Kong Med J. 2013 Oct;19(5):400-6. doi: 10.12809/hkmj133964. Epub 2013 Aug 8.
To evaluate the association between patient age, other clinical factors and mortality following radical cystectomy for treatment of bladder cancer.
Historical cohort study.
A urology unit in Hong Kong.
The outcomes of 117 patients who had radical cystectomies performed in one urological unit from 2003 to 2011 were reviewed. Demographic and perioperative data, including tumour stage, Charlson Comorbidity Index, and preoperative serum albumin levels were retrieved from computerised medical records. Risk factors for 30-day mortality, and cancer-specific, other-cause, and overall death rates at 5 years were calculated. The data were subsequently stratified and analysed according to age.
Of the 117 patients, 83 (71%) were aged 75 years or below. The mean follow-up duration was 31 (standard deviation, 29) months. Age, tumour stage, and preoperative serum albumin level, but not the Charlson Comorbidity Index, were found to be predictors of survival following radical cystectomy. The overall 30-day mortality rate was 3% in the full sample, 1% in patients aged 75 years or below, and 10% in patients aged over 75 years. There was no significant difference in 5-year cancer-caused mortalities between patients aged 75 years or below and those aged over 75 years (33% vs 33%, P=0.956). In patients older than 75 years, the 5-year other-cause and overall mortality rates were 47% and 80%, respectively; such rates were higher than those for younger patients (13% and 46%, respectively).
Age, tumour stage, and preoperative serum albumin level were predictors of survival after radical cystectomy. Non-cancer-related death played a crucial role in the overall mortality rate in elderly patients having radical cystectomy for bladder cancer.
评估患者年龄、其他临床因素与膀胱癌根治性膀胱切除术治疗后死亡率之间的关系。
历史队列研究。
香港的一个泌尿科病房。
回顾了 2003 年至 2011 年在一个泌尿科病房进行根治性膀胱切除术的 117 例患者的结局。从计算机化的医疗记录中检索了人口统计学和围手术期数据,包括肿瘤分期、Charlson 合并症指数和术前血清白蛋白水平。计算了 30 天死亡率以及 5 年时癌症特异性、其他原因和总死亡率的危险因素。随后根据年龄对数据进行分层和分析。
在 117 例患者中,83 例(71%)年龄在 75 岁或以下。平均随访时间为 31(标准差 29)个月。年龄、肿瘤分期和术前血清白蛋白水平,但不是 Charlson 合并症指数,是根治性膀胱切除术后生存的预测因素。总 30 天死亡率在全样本中为 3%,在 75 岁或以下的患者中为 1%,在 75 岁以上的患者中为 10%。在 75 岁或以下的患者和 75 岁以上的患者中,5 年癌症导致的死亡率无显著差异(33%对 33%,P=0.956)。在年龄大于 75 岁的患者中,5 年其他原因和总死亡率分别为 47%和 80%;这些比率高于年轻患者(分别为 13%和 46%)。
年龄、肿瘤分期和术前血清白蛋白水平是根治性膀胱切除术后生存的预测因素。非癌症相关死亡在老年膀胱癌根治性膀胱切除术后的总死亡率中起着关键作用。